Advisory Board April 5, 2024
To combat the ongoing opioid crisis, FDA has approved a new genetic test to identify patients’ potential risk of developing opioid use disorder (OUD). However, a group of health experts have expressed skepticism about the test’s effectiveness, arguing that inaccurate test results could lead to more harm for patients.
Cheat sheet: How to assess the value of a genetic test
Can a genetic test predict your risk for opioid addiction?
In December, FDA approved a DNA test called AvertD, which helps providers identify patients’ risk of developing an opioid addiction. The test is intended to be used by providers before they prescribe a patient with an opioid for the first time, including before they have surgery. It’s not meant for...
Today's Sponsors
Today's Sponsor